|
|
|
|
|
|
Prescriptions
(pdf, 248.51 KB)
|
04 Jan, 2013
|
Global
|
Big pharma’s growth challenge andimplications for deals
|
|
|
Technical Line Implementing the medical device excise tax
(pdf, 99.49 KB)
|
06 Dec, 2012
|
Global
|
An excise tax1 of 2.3% on the sale, lease, rental or use of certain medical devices was mandated by the 2010 health care reform legislation
|
|
|
Pulse medical technology report 2012
(pdf, 3.58 MB)
|
25 Sep, 2012
|
Global
|
How do your financing and M&A plans compare to our annual findings? Know more.
|
|
Cash on the prescription 2012
(pdf, 756.46 KB)
|
12 Sep, 2012
|
Global
|
Cash on prescription 2012 is the latest in a series of working capital management reports published by Ernst & Young.
|
|
|
Progressions - Building Pharma-3.0
(pdf, 3.53 MB)
|
22 Jun, 2012
|
Global
|
Progressions Building Pharma 3.0
|
|
Beyond borders 2012
(pdf, 3.78 MB)
|
18 Jun, 2012
|
Global
|
Beyond borders
|
|
|
Progressions 2012: health care everywhere
(pdf, 4.39 MB)
|
09 Mar, 2012
|
Global
|
Disruptive innovations and unsustainable costs are propelling life sciences companies into the behavioral change business. Learn why in our annual life sciences report.
|
|
Global pharmaceutical industry report 2010: Progressions Pharma 3.0
(pdf, 4.13 MB)
|
02 Mar, 2012
|
Global
|
This is a report on Global pharmaceutical industry on the progressions of Pharma 3.0
|
|
German biotechnology report 2011_PDF
(pdf, 3.50 MB)
|
30 Nov, 2011
|
Global
|
Can the German biotech industry continue to grow at a pace that will help it maintain a sustainable future? Learn more about the defining events.
|
|
|
2011 Italian Biotechnology Report
(pdf, 3.38 MB)
|
10 Nov, 2011
|
Global
|
How is the Italian biotechnology field balancing its growth in human health, agro-food, and industry work? Learn more about this growing market.
|
